©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
Translational Initiation Factor eIF-4E
A LINK BETWEEN CARDIAC LOAD AND PROTEIN SYNTHESIS (*)

(Received for publication, November 30, 1995; and in revised form, January 18, 1996)

Hisayasu Wada Charles T. Ivester Blase A. Carabello George Cooper IV Paul J. McDermott (§)

From the Departments of Medicine, Physiology, and Cell Biology and Anatomy, Gazes Cardiac Research Institute and Veterans Administration Medical Center, Charleston, South Carolina 29401-5799

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES

ABSTRACT

To define the coupling mechanism between cardiac load and the rate of protein synthesis, changes in the extent of eIF-4E phosphorylation were measured after imposition of a load. Electrically stimulated contraction of adult feline cardiocytes increased eIF-4E phosphorylation to 34% after 4 h, as compared with 8% phosphorylation in quiescent controls. However, eIF-4E phosphorylation did not increase upon electrical stimulation in the presence of 7.5 mM 2,3-butanedione monoxime, an inhibitor of actin-myosin cross-bridge cycling and active tension development. Treatment of adult cardiocytes with either 0.1 µM insulin or 0.1 µM phorbol 12-myristate 13-acetate increased eIF-4E phosphorylation to 23 and 64%, respectively, but these increases were not blocked by 2,3-butanedione monoxime. In canine models of acute hemodynamic overload in vivo, eIF-4E phosphorylation increased to 23% in response to left ventricular pressure overload as compared with 7% phosphorylation in controls. Acute volume overload had no effect on eIF-4E phosphorylation. These changes in eIF-4E phosphorylation account for differences in anabolic responses to acute pressure versus acute volume overload. These data suggest that eIF-4E phosphorylation is a mechanism by which increased cardiac load is coupled to accelerated rates of protein synthesis.


INTRODUCTION

In the adult mammal, cardiac muscle grows by hypertrophy of the constituent terminally differentiated muscle cells or cardiocytes(1) . In contrast to hyperplastic growth that is regulated at multiple levels, hypertrophic growth is primarily regulated at the level of protein translation, since the eventual increase in mass is a function of the net difference between rates of protein synthesis and protein degradation(2) . A nearly universal feature of cardiac hypertrophy in the adult is that it is the basic compensatory mechanism for increased hemodynamic load. The amount of hypertrophy that develops in vivo is dependent upon the type, severity, and duration of the increased ventricular wall stress imposed by a load, and it can be accounted for by quantitative differences in protein synthesis rates that are intrinsic to the cardiocyte(3, 4, 5, 6, 7) . However, the coupling mechanism between load and hypertrophy is unknown. Therefore, in an attempt to define this mechanism, we focused on the rate-limiting steps involved in regulating protein translation in response to load.

Many studies indicate that the initial acceleration of the rate of protein synthesis in response to an acute increase in load results from increased translational efficiency, in which a greater amount of protein is produced by the preexistent translational machinery in the cardiocyte(3, 4, 6, 8, 9) . Increased translational efficiency usually occurs at the level of peptide chain initiation and is controlled by modifying the activities of translational initiation factors via phosphorylation and dephosphorylation(10, 11) . Thus, changes in the activity of an initiation factor that is rate-limiting for peptide chain initiation would provide a specific mechanism for accelerating cardiocyte protein synthesis. One such mechanism that regulates the overall rate of protein synthesis is the formation of the 48 S initiation complex, which is formed by the binding of mRNA to the 43 S initiation complex and is catalyzed by the activities of eIF-4F and eIF-4B(10, 11, 12) . The eIF-4F complex consists of three components: a cap binding protein referred to as eIF-4E that binds to the m^7-GTP cap of mRNA, eIF-4A that functions as a helicase along with eIF-4B to unwind mRNA secondary structure, and eIF-4 that functions as a binding protein for the eIF-4 protein group. The assembly of the eIF-4F complex occurs either prior to mRNA binding or sequentially during the process of mRNA binding to the 40 S ribosome(12, 13) . Although all of the eIF-4 proteins are phosphorylated with the exception of eIF-4A several lines of evidence indicate that eIF-4E activity, which is a function of its phosphorylation state, is rate-limiting for peptide chain initiation and therefore regulates the rate of protein synthesis. First, a large number of studies have shown a direct correlation between the extent of eIF-4E phosphorylation and the rate of protein synthesis(10, 11, 12) . Second, it is the least abundant eIF and is present in limiting quantities relative to mRNA and ribosomes(14) . Third, eIF-4E activity is increased by phosphorylation on serine 209, which increases its binding affinity for the m^7-GTP caps on mRNA and thereby promotes assembly of eIF-4F in the initiation complex(15) .

Given the regulatory potential of a rate-limiting translation factor, we hypothesized that eIF-4E phosphorylation might be the coupling mechanism by which an acute change in load accelerates the rate of protein synthesis. We determined whether changes in eIF-4E phosphorylation, a direct measure of its activity, occur in response to acute changes in load by using an in vitro model of electrically stimulated contraction of adult feline cardiocytes in primary culture and in vivo models of canine left ventricular pressure and volume overload. In electrically stimulated cardiocytes in vitro, prior studies had demonstrated that the rate of protein synthesis was acutely accelerated in response to the active as opposed to the passive tension component of cardiocyte contraction, and long term stimulation resulted in a sustained increase in protein synthesis and hypertrophic growth(4, 16) . In the experimental models of hemodynamic overload in vivo, we have previously shown that the rate of myosin synthesis was significantly increased in response to acute pressure overload but not in response to acute volume overload(3) . Therefore, in this study, both the in vitro and in vivo models were employed to determine whether eIF-4E phosphorylation is a mechanism for accelerating rates of protein synthesis in response to increased mechanical load.


MATERIALS AND METHODS

Electrical Stimulation Model

Adult feline cardiocytes were isolated for primary culture by collagenase digestion in combination with mechanical agitation as described previously(4) . Following cell isolation, the Ca-tolerant cardiocytes were suspended in M199 (Life Technologies, Inc.) medium with Earle's balanced salts at a concentration of 50,000 rod-shaped cells/ml. The cardiocytes were plated onto four-well culture trays (Nunc); the dimensions of each well were 2.5 times 6.5 cm. To facilitate adhesion, the wells were coated with laminin and the cardiocytes plated in M199 medium at a density of 2 times 10^5 rod-shaped cardiocytes/well. Fibroblast contamination was minimized by differential adhesion after 1 h of incubation. Following an overnight incubation, the cultures were rinsed to remove nonadherent cardiocytes and incubated in a chemically defined serum-free medium consisting of M199 medium supplemented with 250 µM ascorbic acid and 1.8 mM sodium acetate. Adult feline cardiocytes, which are normally quiescent in culture, were induced to contract synchronously via electrical field stimulation as described previously(16) . Cardiocyte contraction was stimulated at a frequency of 1 Hz and pulse duration of 5 ms.

Canine Models of Acute Pressure and Volume Overload

The canine models of acute hemodynamic overload were prepared as described (3) . In the acute pressure overload model, averaged hemodynamic data over 6 h demonstrated that systolic pressure was increased by 44% over that of control dogs and was accompanied by significant increases in stroke work, pulmonary wedge pressure and diastolic pressure. In the acute volume overload model, hemodynamic data showed that the average regurgitant fraction was 67 ± 6% of control, and the stroke volume and pulmonary wedge pressure were increased by 57 and 130%, respectively.

Purification of eIF-4E from Cardiocytes

Each well was rinsed twice with 3 ml of ice-cold Hanks' balanced salt solution (Life Technologies, Inc.). The cells were scraped in LCB buffer (100 µl/well) consisting of 20 mM HEPES, pH 7.5, 100 mM KCl, 0.2 mM EDTA, 7 mM beta-mercaptoethanol, 10% (v/v) glycerol, 0.5% (v/v) Triton X-100, 80 mM 2-glycerophosphate, 50 mM NaF, 0.2 mM phenylmethylsulfonyl fluoride, 1 mM benzamidine, 0.5 mM sodium orthovanadate, 1 µM okadaic acid, 1 µM microcystin LR, 25 µg/ml leupeptin, 2 units/ml aprotinin, and 20 µg/ml chymostatin. The material from eight wells (two culture trays) was pooled and homogenized by means of a Dounce homogenizer. 20 µl of washed m^7-GTP-Sepharose 4B (Pharmacia Biotech Inc.) was added to each sample and incubated for 1 h at 4 °C. The m^7-GTP-Sepharose was pelleted, washed three times with LCB buffer, and resuspended in 48 µl of HB buffer consisting of 20 mM HEPES, pH 7.5, 100 mM KCl, 0.2 mM EDTA, 80 mM 2-glycerophosphate, 50 mM NaF, 1 mM dithiothreitol, 0.2 mM phenylmethylsulfonyl fluoride, 1 mM benzamidine, 0.5 mM sodium orthovanadate, 1 µM okadaic acid, and 1 µM microcystin. 12 µl of solution D (10% SDS, 150 mM dithiothreitol) was added,and the samples were boiled for 3 min and allowed to cool to room temperature. 48 µl of solution E (65 mM dithiothreitol, 4% (w/v) CHAPS, (^1)9 M urea) was then added, and the samples were frozen using liquid N(2) and stored at -70 °C prior to isoelectric focusing.

Purification of eIF-4E from Canine Myocardium

For the canine myocardium, 100 mg of frozen tissue samples were homogenized in 1 ml of LCB buffer using a Polytron followed by a Dounce homogenizer. eIF-4E was purified from the homogenates using m^7-GTP-Sepharose as described above.

eIF-4E Antibody

Human recombinant eIF-4E, cloned into the expression vector pET-IId-4E (Novagen), was expressed in Escherichia coli and purified as described(17) . This protein was used as a standard and to generate a rabbit polyclonal eIF-4E-antibody.

Isoelectric Focusing of eIF-4E

One-dimensional isoelectric focusing on vertical slab gels (VSIEF) was performed as described with modifications(18) . The gels consisted of 4% polyacrylamide, 0.1% bisacrylamide, 9.0 M urea, 4.3% ampholytes, pH 5-7 (Bio-Rad), 1.1% ampholytes, pH 3-10, 1.6% CHAPS, and 0.54% Nonidet P-40. After prefocusing of the gels at 200 V for 15 min, 300 V for 15 min, and 400 V for 5 min, the samples were loaded and overlaid with 5% ampholines. Isoelectric focusing was carried out for 15 h at 600 V and increased to 800 V for 1 h for a total of 9800 volt hours.

Western Blot Analysis

For Western blotting, gels were equilibrated in transfer buffer (25 mM Tris, pH 8.3, 192 mM glycine, 0.1% SDS) for 10 min and transferred to Immobilon membranes (Millipore Corp.) over 2 h at 30 V using an Excell II Minicell transfer apparatus (Novex). The membranes were incubated overnight in blocking buffer consisting of 10% nonfat dry milk in TBS-T buffer (20 mM Tris, pH 7.6, 137 mM NaCl, 0.1% Tween 20), washed five times in TBS-T buffer, and incubated overnight in primary eIF-4E antibody diluted to 1:5000 in TBS-T. The membranes were washed in TBS-T, and the secondary antibody detection was carried out for 1 h in horseradish peroxidase-coupled anti-rabbit IgG (Vector Laboratories, Inc.) diluted 1:10,000 in TBS-T. The membranes were washed with TBS-T buffer, and detection was carried out using a Renaissance chemiluminescence detection system (DuPont).

m^7-GTP-Sepharose Affinity Chromatography

Recombinant eIF-4E was resuspended in LCB buffer and added to an m^7-GTP-Sepharose column equilibrated with LCB. The column was washed three times with LCB and eluted with 100 µM m^7-GTP. The protein in the washes and the eluate were precipitated overnight in 10% C(2)HCl(3)O(2) using bovine serum albumin as a carrier. The pellets were washed with acetone, electrophoresed on 15% SDS-PAGE gels, and Western blotted with eIF-4E antibody. The same procedure was used for cardiocytes following homogenization in LCB buffer.

Immunoprecipitation of eIF-4E from Feline Cardiocytes

Cardiocytes were rinsed twice with ice-cold M199 medium and scraped in a buffer containing 20 mM Tris, pH 7.5, 0.5 mM EGTA, 0.5 mM EDTA, 0.1 mM phenylmethylsulfonyl fluoride, 0.4 mM dithiothreitol, 1% Nonidet P-40, 1% SDS, 0.5 µg/ml leupeptin, 1 mM sodium orthovanadate, 80 mM beta-glycerophosphate, 1% sodium deoxycholate, 50 mM NaF, and 10 mM Na(4)P(2)O(7). The homogenate was incubated on ice for 1 h, centrifuged for 10 min at 13,000 times g, and incubated overnight with eIF-4E antibody. eIF-4E was immunoprecipitated by incubating for 1 h with Protein A-Sepharose (Pierce). The samples were pelleted, washed, and subjected to SDS-PAGE followed by Western blotting with eIF-4E antibody.

Western Blot Analysis of Total Cell Protein

Cardiocyte cultures were rinsed and homogenized in LCB buffer using a Dounce homogenizer as described above. Protein concentration was determined using the BCA method (Pierce). 100-µg aliquots of total cell protein were subjected to SDS-PAGE using 15% polyacrylamide gels, followed by Western blotting. For canine myocardial samples, frozen samples from the left ventricle and companion right ventricle were homogenized in LCB buffer by means of a Polytron followed by Dounce homogenization, and 100-µg aliquots of total tissue protein were electrophoresed by SDS-PAGE using 15% polyacrylamide gels followed by Western blotting.


RESULTS

Changes in eIF-4E activity, as measured by the extent of eIF-4E phosphorylation on isoelectric focusing gels, were assessed in cardiocyte homogenates following purification by affinity chromatography with m^7-GTP-Sepharose and detection by Western blotting using a polyclonal antibody for eIF-4E. The validity of this approach is demonstrated in Fig. 1by five criteria. First, as shown previously(17) , human recombinant eIF-4E bound to an m^7-GTP-Sepharose affinity column and was eluted by m^7-GTP (Fig. 1A); the eIF-4E antibody recognized recombinant eIF-4E on Western blots. Second, eIF-4E was purified from homogenates of both quiescent control and electrically stimulated cardiocytes using the m^7-GTP-Sepharose affinity column; a protein of the same electrophoretic mobility as human eIF-4E (28 kDa) was detected by Western blotting (Fig. 1B). Third, to further demonstrate the specificity of the polyclonal antibody, eIF-4E was immunoprecipitated from the cardiocyte homogenate without the m^7-GTP-Sepharose affinity purification step (Fig. 1C); a single protein band having the same electrophoretic mobility as human recombinant eIF-4E was detected by Western blotting. Fourth, the phosphorylated and nonphosphorylated forms of eIF-4E were resolved in cardiocyte homogenates by one-dimensional VSIEF and detected by Western blotting with eIF-4E antibody. As is shown in Fig. 1D, steady state levels of phosphorylated eIF-4E were very low in quiescent cardiocytes; however, phorbol ester treatment of cardiocytes for 4 h caused a shift of nonphosphorylated eIF-4E into the phosphorylated eIF-4E pool; the isoelectric points of nonphosphorylated and phosphorylated eIF-4E were pH 6.2 and 5.8, respectively. Fifth, treatment of the homogenate obtained from phorbol ester-stimulated cardiocytes with alkaline phosphatase shifted eIF-4E back into the nonphosphorylated form (Fig. 1D). As an additional control, cardiocytes were radiolabeled overnight with [P]PO(4) and then treated with phorbol ester for 4 h. eIF-4E was purified from the homogenates using m^7-GTP-Sepharose, resolved by VSIEF, and transferred to an Immobilon membrane. A radiolabeled band co-migrated with phosphorylated eIF-4E detected on Western blots (Fig. 1D).


Figure 1: Purification and identification of eIF-4E in cardiocytes. A, characterization of human recombinant eIF-4E standard. Lane 1, recombinant eIF-4E applied to an m^7-GTP-Sepharose column; lane 2, eIF-4E in the LCB wash; lane 3, eIF-4E eluted from the column with 100 µM m^7-GTP. The protein in each fraction was precipitated and used for Western blot analysis. B, purification of eIF-4E from quiescent (Control) and electrically stimulated (Stim) cardiocytes by m^7-GTP-Sepharose column chromatography. C, immunoprecipitation of eIF-4E from feline cardiocytes. Lane 1, eIF-4E standard; lane 2, immunoprecipitated eIF-4E from feline cardiocytes. D, identification of nonphosphorylated and phosphorylated eIF-4E in feline cardiocytes. eIF-4E was purified from cardiocyte homogenates with m^7-GTP-Sepharose and resolved by VSIEF followed by Western blotting. The phosphorylated and nonphosphorylated forms of eIF-4E are as indicated. Lane 1, control cardiocytes; lane 2, cardiocytes treated with 0.1 µM phorbol 12-myristate 13-acetate (PMA) for 4 h; lane 3, phorbol 12-myristate 13-acetate-treated cardiocytes were homogenized in LCB buffer without phosphatase inhibitors and incubated in the presence of 950 units of calf intestinal alkaline phosphatase (Sigma) for 1 h at 37 °C prior to adding m^7-GTP-Sepharose. Lane 4, cardiocytes were treated overnight with [P]PO(4) prior to phorbol 12-myristate 13-acetate treatment for 4 h in the presence of [P]PO(4). eIF-4E was affinity purified from the homogenate and subjected to VSIEF. Following transfer, this lane was subjected to autoradiography.



Our previous studies showed that electrically stimulated contraction of adult cardiocytes resulted in a time-dependent increase in protein synthesis that reached 43% after 4 h(4) . In order to determine whether the rate of protein synthesis was increased by a mechanism involving phosphorylation of eIF-4E, cardiocytes were electrically stimulated to contract at a frequency of 1 Hz, and the extent of eIF-4E phosphorylation was measured as a function of time (Fig. 2). There was a time-dependent increase in the percentage of eIF-4E phosphorylation from 4% in the quiescent controls to 33% after 4 h of electrically stimulated contraction. Our previous studies also showed that the rate of protein synthesis was accelerated by the mechanical component of cardiocyte contraction, as defined by active tension development and shortening. To determine whether load in the form of mechanical contraction was the stimulus that increased eIF-4E phosphorylation, cardiocytes were electrically stimulated for 4 h in the presence and absence of 2,3-butanedione monoxime (BDM), and the extent of eIF-4E phosphorylation was measured. BDM is a chemical agent that blocks actin-myosin cross-bridge cycling and force development without any significant effects on calcium transients at concentrations lower than 10 mM, in effect uncoupling electrical excitation from contraction(19) . We have shown that 7.5 mM BDM completely blocks the ability of electrical stimulation to accelerate the rate of cardiocyte protein synthesis; concurrently it reduces both the extent and velocity of sarcomere shortening by 70% and the extent of cell shortening by 90%(4) . In the absence of BDM, electrically stimulated contraction for 4 h significantly increased eIF-4E phosphorylation as compared with that of quiescent controls (Fig. 3). In contrast, eIF-4E phosphorylation was not increased when cardiocytes were electrically stimulated in the presence of 7.5 mM BDM. BDM had no effect on eIF-4E phosphorylation of quiescent controls. Thus, the extent of eIF-4E phosphorylation correlates with changes in the rate of protein synthesis since both were increased in response to a work load consisting of active tension development during cardiocyte contraction.


Figure 2: Effects of electrically stimulated contraction of eIF-4E phosphorylation in adult feline cardiocytes. Cardiocytes on day 1 in culture were electrically stimulated to contract (Stim) using pulses of alternating polarity at a frequency of 1 Hz and pulse duration of 5 ms. At the indicated time points, eIF-4E was purified from cardiocyte homogenates and resolved by VSIEF followed by Western blotting. The phosphorylated and nonphosphorylated forms of eIF-4E are as indicated. Non-stimulated cardiocytes were used as the control. As determined by digital image analysis, the percentage of phosphorylated eIF-4E increased from 4% in the controls to 16, 25, and 33% after 1, 2, and 4 h of electrical stimulation, respectively.




Figure 3: Comparative effects of contraction, insulin, and phorbol ester on eIF-4E phosphorylation in adult cardiocytes. A, adult cardiocytes on day 1 in culture were subjected to the following treatments: Control, quiescent controls; Stim, electrically stimulated contraction at 1 Hz and 5-ms pulse duration; Ins, 0.1 µM recombinant insulin; PMA, 0.1 µM phorbol 12-myristate 13-acetate. Each treatment was performed for 4 h in the presence or absence of 7.5 mM BDM. eIF-4E was affinity purified from cardiocyte homogenates with m^7-GTP-Sepharose. The samples were subjected to VSIEF followed by Western blotting using the eIF-4E antibody. The autoradiogram shows a representative blot containing samples from each treatment group. B, summary data of the percentages of eIF-4E phosphorylation in each of the treatment groups as determined by digital image analysis of the autoradiograms. Values are the mean + S.E., n = 3 experiments. Statistical comparisons were made by analysis of variance followed by a Student-Newman-Keuls test. *, p < 0.01 as compared with quiescent controls, #, p < 0.01 between electrically stimulated cardiocytes in the presence or absence of 7.5 mM BDM.



Insulin has been shown to increase both protein synthesis and eIF-4E phosphorylation(20) . Because we have found that insulin acutely accelerates the rate of protein synthesis in quiescent cardiocytes (16) , the effect of 0.1 µM insulin on eIF-4E phosphorylation was determined (Fig. 3). As measured after 4 h, insulin stimulated eIF-4E phosphorylation in quiescent cardiocytes to the same extent as did electrically stimulated contraction. However, in contrast to electrical stimulation, BDM did not affect the insulin-stimulated increase in eIF-4E phosphorylation, indicating that insulin has a signaling mechanism for eIF-4E phosphorylation that is distinct from that utilized by cardiocyte contraction. eIF-4E has also been shown to be a substrate for protein kinase C in vitro, and eIF-4E phosphorylation occurs in response to phorbol ester treatment in several cell types(20) . Because protein kinase C activation may have an important role in regulating hypertrophic growth of cardiocytes(7, 21) , we examined whether direct activation of the catalytic subunit of protein kinase C by phorbol ester treatment increased eIF-4E phosphorylation (Fig. 3). Phorbol ester treatment of quiescent cardiocytes for 4 h caused a marked increase in eIF-4E phosphorylation that was approximately twice that observed in response to either contraction or insulin. BDM treatment had no effect on eIF-4E phosphorylation in phorbol ester-treated cardiocytes. Thus, three distinct stimuli for accelerating the rate of protein synthesis, namely load as induced by electrically stimulated contraction, insulin treatment, and activation of protein kinase C with phorbol ester share a common anabolic end point of eIF-4E phosphorylation, even though they utilize unique signaling mechanisms. The fact that BDM did not affect eIF-4E phosphorylation in response to either insulin or phorbol ester treatment shows that its inhibition of eIF-4E phosphorylation in electrically stimulated cardiocytes is caused by blockade of active tension development and cell shortening and is not the result of a phosphatase activity or other nonspecific effects on phosphorylated eIF-4E.

To determine whether the mechanical effects of cardiocyte contraction on eIF-4E phosphorylation in vitro have relevance to load-induced cardiac hypertrophy in vivo, eIF-4E phosphorylation was measured in experimental canine models of acute pressure and volume overload in vivo(3) . These two distinct types of left ventricular hemodynamic overload exert different types and severities of wall stress. Aortic stenosis (AS) is a pressure overload characterized by an increase in systolic wall stress as the stroke volume is pumped under higher pressure into the aorta. Sustained pressure overload results in the development of concentric hypertrophy and increased wall thickness. In contrast, mitral valve regurgitation (MR) is a volume overload in which the excess volume is ejected into the left atrium under low pressure. There is an increase in diastolic wall stress that causes the development of eccentric hypertrophy, but the amount of hypertrophy produced by MR is generally much less than that produced by substantial pressure overload(3) . Indeed, we have determined that AS accelerates the rate of myosin synthesis by 45%, whereas MR has no significant effect on the rate of myosin synthesis (3) . Therefore, the phosphorylation of eIF-4E in response to AS and MR was compared in the same cardiac tissue samples in which the disparate effects of AS and MR on the rate of myosin synthesis had been found. As shown in Fig. 4, pressure overload of the left ventricle by AS caused an increase in eIF-4E phosphorylation as compared with the left ventricle of sham-operated control dogs. In contrast, volume overload of the left ventricle by MR did not stimulate eIF-4E phosphorylation. As an internal, more normally loaded, control for each heart, there was no significant effect on eIF-4E phosphorylation in the companion right ventricles in any of the treatment groups. Thus, increased eIF-4E phosphorylation was dependent upon the type of wall stress imposed upon the myocardium, consistent with previous findings that the rate of protein synthesis is accelerated in response to an increase in systolic wall stress produced by acute pressure overload, but not in response to an increase in diastolic stress produced by acute volume overload.


Figure 4: Changes in eIF-4E phosphorylation in response to acute pressure and acute volume overload in dogs. A, AS and MR were maintained for 6 h, and eIF-4E phosphorylation was compared with that in sham-operated controls. The autoradiogram shows a representative blot containing samples from each treatment group for the left ventricle (LV) and the companion right ventricle (RV) of each heart. B, summary data. The data are expressed as the mean ± S.E., n = 5 dogs per treatment group. *, P < 0.01 as determined by an analysis of variance followed by a Student-Newman-Keuls test.



There are potentially two ways to increase the activity of eIF-4E in the cardiocyte: increased phosphorylation of eIF-4E and/or an increase in the amount of eIF-4E. We measured the relative amounts of eIF-4E in total cardiocyte or total myocardial tissue homogenates by Western blotting (Fig. 5). The data in Fig. 5A show that eIF-4E levels did not increase after 4 h of electrically stimulated contractile activity, insulin treatment, or phorbol ester treatment when compared with control levels. There were no differences in eIF-4E levels among any of the treatment groups as determined by digital image analysis of two experiments; the coefficient of variation in eIF-4E levels was 4.4%. The data in Fig. 5B show that eIF-4E levels did not increase after 6 h in the canine models of either pressure overload from AS or volume overload from MR. As determined by digital image analysis, the coefficient of variation in eIF-4E levels was 6.8% (two experiments). Thus, changes in eIF-4E phosphorylation occurred without increases in the overall amount of eIF-4E protein.


Figure 5: Effects of acute, mechanical load on eIF-4E levels. A, representative Western blot using total protein from cardiocyte homogenates. Cardiocytes on day 1 in culture were treated for 4 h as follows: Control, quiescent cardiocytes; Ins, 0.1 µM recombinant insulin; PMA, 0.1 µM phorbol 12-myristate 13-acetate; Stim, electrically stimulated contraction at 1 Hz and 5-ms pulse duration. B, Western blot using total tissue homogenates from control, pressure-overloaded (AS), and volume-overloaded (MR) myocardium. LV, left ventricle; RV, right ventricle.




DISCUSSION

These studies demonstrate a link between the mechanical stimulus of load on the cardiocyte and phosphorylation of eIF-4E. By increasing the activity of eIF-4E through phosphorylation, a specific coupling mechanism is established for enhancing peptide chain initiation and thereby accelerating the steady state rate of protein synthesis. This same mechanism applies to acute models of load-induced hypertrophy in vivo since eIF-4E was phosphorylated in response to the severe increase in systolic stress caused by a pressure overload but not in response to increased diastolic stress produced by a volume overload. Thus, the mechanism involved in eIF-4E phosphorylation distinguishes between the types of wall stress associated with pressure versus volume overload, and the quantitative difference in the rate of protein synthesis observed in these two models correlates with the extent of eIF-4E phosphorylation. In a terminally differentiated cell such as the adult cardiocyte, this type of translational mechanism could coordinate the acceleration of total protein synthesis in response to load. Thus, constitutively expressed proteins of high abundance, which are translated efficiently, could be increased both rapidly and proportionally by effectively competing for the limited amount of activated eIF-4E. Our prior work showed that cardiocyte contraction accelerated the synthesis rate of the high abundance protein myosin heavy chain to the same extent as that of total cell protein, and there was an increased rate of translational initiation for myosin heavy chain mRNA(4, 22) . Furthermore, as part of an early response, increased eIF-4E phosphorylation could potentially augment the translational initiation of growth-related mRNAs that operate downstream either to sustain or to further increase the hypertrophic response. An overall increase in initiation rate could increase the translation of growth-related mRNAs by removing the inhibition caused by excessive secondary structure in the 5`-untranslated region or by increasing the probability of initiation on mRNA species that are normally ``weak'' with respect to translation(14, 23) .

The specific kinases and/or phosphatases that may be involved in regulating eIF-4E phosphorylation in response to mechanical input remain to be determined. The dependence of eIF-4E phosphorylation on active tension development suggests that a different mechanism is involved than that utilized either by insulin treatment or by direct activation of protein kinase C with phorbol esters. Even though these stimuli utilize the same anabolic end point, the presence of multiple mechanisms is consistent with the fact that several known kinases can phosphorylate eIF-4E in vitro, including protein kinase C and cPK, an insulin-stimulated protamine kinase(20, 24) . However, the identity of the kinase(s) and/or phosphatase(s) for eIF-4E in vivo are not known. An increase in eIF-4E phosphorylation does not preclude the possibility that other initiation factors are also rate-limiting for translational initiation in response to load, perhaps through protein-protein interactions or phosphorylation. For example, the activity of eIF-4E is enhanced through eIF-4F that is assembled either prior to or during the process of 48 S initiation complex formation(12, 13, 20) . Many other initiation factors including eIF-4 and eIF-4B are phosphorylated, but their functional significance has not been determined. Another protein that can regulate eIF-4E activity is the eIF-4E binding protein PHAS-1(25, 26) . The activity of phosphorylated eIF-4E is inhibited by its binding to PHAS-1, even though the affinity for the m^7-GTP cap is unaffected. In insulin-treated cells, phosphorylation of PHAS-1 prevents binding to eIF-4E, thereby removing its inhibitory effect on eIF-4E function. Given the observation that PHAS-1 is phosphorylated through several kinase pathways(25) , it could potentially be an additional mechanism for regulating eIF-4E activity in response to mechanical load.

In summary, a specific anabolic end point has been identified that links an acute increase in mechanical load to an accelerated rate of cardiocyte protein synthesis. The change in eIF-4E phosphorylation provides a mechanism coupling load to increased peptide chain initiation and thus to accelerated protein synthesis. While applicable to the terminally differentiated cardiac muscle cell, this mechanism may have much broader implications for other systems in which mechanical forces regulate growth(27) . For example, a considerable fraction of the protein synthesizing machinery, including initiation factors, mRNA, and polyribosomes, are physically associated with cytoskeletal components in all cells(28) , such that eIF-4E may be a coupling molecule to convert mechanically induced changes in the cytoskeleton into an anabolic response.


FOOTNOTES

*
This work was supported by National Institutes of Health Grant PO1 HL-48788 (to G. C., B. A. C., and P. J. M.) and the Research Service of the Department of Veterans Affairs (to G. C., B. A. C., and P. J. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§
To whom correspondence should be addressed: Cardiology Section/VA Medical Center, 109 Bee St., Charleston, SC 29401-5799. Tel.: 803-577-5011 (ext. 7594); Fax: 803-723-1535; paul_mcdermott{at}smtpgw.musc.edu.

(^1)
The abbreviations used are: CHAPS, 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid; PAGE, polyacrylamide gel electrophoresis; VSIEF, vertical slab isoelectric focusing; BDM, 2,3-butanedione monoxime; AS, aortic stenosis; MR, mitral valve regurgitation.


ACKNOWLEDGEMENTS

We thank Dr. Rosemary Jagus for generously providing the human recombinant eIF-4E expression vector pET-IId-4E and Paul T. Cantey, Logan Robertson, Mary Barnes, and Pat Kilroy for technical assistance.


REFERENCES

  1. Cooper, G., IV (1987) Annu. Rev. Physiol. 49, 501-518 [CrossRef][Medline] [Order article via Infotrieve]
  2. Morgan, H. E., Gordon, E. E., Kira Y., Chua, B. H. L., Russo, L. A., Peterson, C. J., McDermott, P. J., and Watson, P. A. (1987) Annu. Rev. Physiol. 49, 533-543 [CrossRef][Medline] [Order article via Infotrieve]
  3. Imamura, T., McDermott, P. J., Kent, R. L., Nagatsu, M., Cooper, G., IV, and Carabello, B. A. (1994) Circ. Res. 75, 418-425 [Abstract]
  4. Ivester, C. T., Kent, R. L., Tagawa, H., Tsutsui, H., Imamura, T., Cooper, G., IV, and McDermott, P. J. (1993) Am. J. Physiol. 265, H666-H674
  5. Mann, D. L., Kent, R. L., and Cooper, G., IV (1989) Circ. Res. 64, 1079-1090 [Abstract]
  6. Kent, R. L., Hoober, J. K., and Cooper, G., IV (1989) Circ. Res. 64, 74-85 [Abstract]
  7. Morgan, H. E. and Baker, K. M. (1991) Circulation 83, 13-25 [Medline] [Order article via Infotrieve]
  8. Kira, Y., Kochel, P. J., Gordon, E. E., and Morgan, H. E. (1984) Am. J. Physiol. 246, C247-C258
  9. Delcayre, C., Klug, D., van Thiem, N., Mouas, C., and Swynghedauw, B. (1992) Am. J. Physiol. 263, H1537-H1545
  10. Rhoads, R. E. (1993) J. Biol. Chem. 268, 3017-3020 [Free Full Text]
  11. Hershey, J. W. B. (1991) Annu. Rev. Biochem. 60, 717-755 [CrossRef][Medline] [Order article via Infotrieve]
  12. Mader, S., and Sonenberg, N. (1995) Biochimie (Paris) 77, 40-44
  13. Minich, W. B., Balasta, M. L., Goss, D. J., and Rhoads, R. E. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 7668-7672 [Abstract]
  14. Rhoads, R. E., Joshi-Barve, S., and Rinker-Schaeffer, C. (1993) Prog. Nucleic Acids Res. Mol. Biol. 46, 183-219 [Medline] [Order article via Infotrieve]
  15. Joshi, B., Cai, A., Keiper, B. D., Minich, W. B., Mendez, R., Beach, C. M., Stepinski, J., Stolarski, R., Darzynkiewicz, E., and Rhoads, R. E. (1995) J. Biol. Chem. 270, 14597-14603 [Abstract/Free Full Text]
  16. Kato, S., Ivester, C. T., Cooper, G., IV, Zile, M. R., and McDermott, P. (1995) Am. J. Physiol. 268, H2495-H2504
  17. Stern, B. D., Wilson, M., and Jagus, R. (1993) Protein Expression Purif. 4, 320-327 [CrossRef][Medline] [Order article via Infotrieve]
  18. Kimball, S. R., and Jefferson, L. S. (1990) J. Biol. Chem. 265, 16794-16798 [Abstract/Free Full Text]
  19. Backx, P. H., Gao, W., Azan-Backx, M. D., and Marbon, E. (1994) J. Physiol. (Lond.) 476, 487-500
  20. Morley, S. J. (1994) Mol. Biol. Rep. 19, 221-231 [Medline] [Order article via Infotrieve]
  21. Clerk, A., Bogoyevitch, M. A., Andersson, M. B., and Sugden, P. H. (1994) J. Biol. Chem. 269, 32848-32857 [Abstract/Free Full Text]
  22. Ivester, C. T., Tuxworth, W. J., Cooper, G., IV, and McDermott, P. J. (1995) J. Biol. Chem. 270, 21950-21957 [Abstract/Free Full Text]
  23. Sonenberg, N. (1994) Curr. Opin. Genet. & Dev. 4, 310-315
  24. Makkinje, A., Xiong, H., Li, M., and Damuni, Z. (1995) J. Biol. Chem. 270, 14824-14828 [Abstract/Free Full Text]
  25. Lin, T., Kong, X., Saltiel, A. R., Blackshear, P. J., and Lawrence, J. C., Jr. (1995) J. Biol. Chem. 270, 18531-18538 [Abstract/Free Full Text]
  26. Pause, A., Belsham, G. J., Gingras, A., Donze, O., Lin, T., Lawrence, J. C., Jr., and Sonenberg, N. (1994) Nature 371, 762-767 [CrossRef][Medline] [Order article via Infotrieve]
  27. Ingber, D. E., Dike, L., Hansen, L., Karp, S., Liley, H., Maniotis, A., McNamee, H., Mooney, D., Plopper, G., Sims, J., and Wang, N. (1994) Int. Rev. Cytol. 150, 173-224 [Medline] [Order article via Infotrieve]
  28. Hesketh, J. E., and Pryme, I. F. (1991) Biochem. J. 277, 1-10 [Medline] [Order article via Infotrieve]

©1996 by The American Society for Biochemistry and Molecular Biology, Inc.